Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,225 | 91,028 | 110,747 | 134,730 | 95,697 |
| Receivables | 2,129 | 1,679 | 2,952 | N/A | N/A |
| Inventories | 1,316 | 1,576 | 1,214 | N/A | N/A |
| TOTAL | $158,575 | $95,369 | $116,450 | $135,551 | $96,883 |
| Non-Current Assets | |||||
| PPE Net | 1,038 | 772 | 676 | 695 | 738 |
| Intangibles | 2,103 | 2,273 | 2,500 | 0 | 0 |
| Other Non-Current Assets | 301 | 311 | 97 | 97 | 97 |
| TOTAL | $3,442 | $3,356 | $3,273 | $792 | $835 |
| Total Assets | $162,017 | $98,725 | $119,723 | $136,343 | $97,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,667 | N/A | 2,667 | 2,667 | 2,667 |
| Accounts payable and accrued liabilities | 9,106 | 8,970 | 6,074 | 6,189 | 3,537 |
| Accrued Expenses | 8,879 | 6,637 | 5,536 | 2,212 | 2,228 |
| TOTAL | $25,596 | $22,212 | $18,203 | $11,068 | $8,432 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,479 | 2,146 | 2,813 | 3,480 | 4,146 |
| Deferred Revenues | 4,944 | 6,605 | 3,926 | N/A | N/A |
| Other Non-Current Liabilities | 34 | 42 | 51 | 59 | 68 |
| TOTAL | $1,513 | $2,188 | $2,864 | $3,539 | $4,214 |
| Total Liabilities | $27,109 | $24,400 | $21,067 | $14,607 | $12,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,449 | 28,611 | 23,528 | 23,527 | 23,507 |
| Common Shares | 29 | 24 | 24 | 24 | 21 |
| Retained earnings | -223,184 | -195,625 | -169,180 | -144,661 | -129,008 |
| Other shareholders' equity | 0 | -3 | -3 | -3 | -3 |
| TOTAL | $134,908 | $74,325 | $98,656 | $121,736 | $85,072 |
| Total Liabilities And Equity | $162,017 | $98,725 | $119,723 | $136,343 | $97,718 |